Prevalence and clinical implications of heightened plastic chemical exposure in pediatric patients undergoing cardiopulmonary bypass
Transfusion · 2024-05 · 64 (5) · 808-823
DOI: 10.1111/trf.17821 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transfusion, online erschienen am 08.04.2024. Verfasst von Devon Guerrelli und 9 weiteren Autor:innen. Beteiligte Einrichtung: Children's National Heart Institute, Children's National Hospital, Washington, DC, USA. Hauptthemen laut MEDLINE: Cardiopulmonary Bypass. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIGMS NIH HHS, NIH HHS.
Abstract (Originalsprache)
Background
Phthalate chemicals are used to manufacture plastic medical products, including many components of cardiopulmonary bypass (CPB) circuits. We aimed to quantify iatrogenic phthalate exposure in pediatric patients undergoing cardiac surgery and examine the link between phthalate exposure and postoperative outcomes. Study Design and Methods The study included pediatric patients undergoing (n=122) unique cardiac surgeries at Children's National Hospital. For each patient, a single plasma sample was collected preoperatively and two additional samples were collected postoperatively upon return from the operating room and the morning after surgery. Concentrations of di(2‐ethylhexyl) phthalate (DEHP) and its metabolites were quantified using ultra high‐pressure liquid chromatography coupled to mass spectrometry.
Results
Patients were subdivided into three groups, according to surgical procedure: (1) cardiac surgery not requiring CPB support, (2) cardiac surgery requiring CPB with a crystalloid prime, and (3) cardiac surgery requiring CPB with red blood cells (RBCs) to prime the circuit. Phthalate metabolites were detected in all patients, and postoperative phthalate levels were highest in patients undergoing CPB with an RBC‐based prime. Age‐matched (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Children's National Heart Institute, Children's National Hospital, Washington, DC, USA.
- Sheikh Zayed Institute for Pediatric Surgical Innovation, Children's National Hospital, Washington, DC, USA.
- Department of Biomedical Engineering, The George Washington University School of Engineering and Applied Science, Washington, DC, USA.
- Division of Cardiac Surgery, Children's National Hospital, Washington, DC, USA.
- Department of Cardiovascular Services - Perfusion, Children's National Hospital, Washington, DC, USA.
- Department of Anesthesiology, Critical Care and Pain Medicine, Department of Surgery, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
ORCID-Profile: Devon Guerrelli, Angelo D'Alessandro, Nikki Gillum Posnack
Förderung
- NHLBI NIH HHS
- NIGMS NIH HHS
- NIH HHS
- National Institutes of Health
- American Heart Association
Zitieren
APA
Guerrelli, D., Desai, M., Semaan, Y., Essa, Y., Zurakowski, D., Cendali, F., Reisz, J., D'Alessandro, A., Luban, N., & Posnack, N. G. (2024). Prevalence and clinical implications of heightened plastic chemical exposure in pediatric patients undergoing cardiopulmonary bypass. Transfusion, 64(5), 808-823. https://doi.org/10.1111/trf.17821
Vancouver
Guerrelli D, Desai M, Semaan Y, Essa Y, Zurakowski D, Cendali F, et al. Prevalence and clinical implications of heightened plastic chemical exposure in pediatric patients undergoing cardiopulmonary bypass. Transfusion. 2024;64(5):808-823. doi:10.1111/trf.17821
BibTeX
@article{Guerrelli2024,
author = {Guerrelli, Devon and Desai, Manan and Semaan, Youssef and Essa, Yasin and Zurakowski, David and Cendali, Francesca and Reisz, Julie and D'Alessandro, Angelo and Luban, Naomi and Posnack, Nikki Gillum},
title = {Prevalence and clinical implications of heightened plastic chemical exposure in pediatric patients undergoing cardiopulmonary bypass},
journal = {Transfusion},
year = {2024},
volume = {64},
number = {5},
pages = {808--823},
doi = {10.1111/trf.17821}
}
EUVIMED